Cite
HARVARD Citation
Hodges-Gallagher, L. et al. (n.d.). OP-1250: A potent orally available complete antagonist of estrogen receptor-mediated signaling that shrinks wild type and mutant breast tumors. European journal of cancer. pp. S55-. [Online].